Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Future Science Group

Science

Activity Overview

Episode publication activity over the past year

Episodes

Showing 101-200 of 304
«« ← Prev Page 2 of 4 Next → »»

FON-2021-1277 OCTalks

26 Apr 2022

Contributed by Lukas

FON-2021-1277 OCTalks by Taylor & Francis Group

The evolution of recombinant antibodies

19 Apr 2022

Contributed by Lukas

In this episode, we discuss recombinant proteins: what are they and what are they used for? BioTechniques Editor Tristan Free speaks to Amy Sheng, T...

Tech Blast | Microbiome data

19 Apr 2022

Contributed by Lukas

In this Tech Blast episode, we discuss generating, standardizing and sharing microbiome data with Raul Cano, Chief Scientific Officer at The BioCollec...

3D and tea: Dolores Serrano and Katerina Lalatsa on 3D printing in cancer studies

12 Apr 2022

Contributed by Lukas

In this '3D and tea' interview, we speak to Dolores Serrano and Katerina Lalatsa all about the potential of utilizing 3D printing in cancer studies.

NCTalks with Jan Hillert: pregnancy outcomes in MS

06 Apr 2022

Contributed by Lukas

NCTalks with Jan Hillert: pregnancy outcomes in MS by Taylor & Francis Group

Flow cytometry for CGT assay development: an interview with Richard Cuthbert

05 Apr 2022

Contributed by Lukas

Flow cytometry for CGT assay development: an interview with Richard Cuthbert by Taylor & Francis Group

The evolution of iChem workflow automation: a podcast with Andrew Hall

01 Apr 2022

Contributed by Lukas

In this podcast, Andrew Hall (Labcorp, UK) discusses the evolution of large molecule bioanalysis workflow automation as well as the present challenges...

Bioanalytical assays for gene therapy programs: an interview with Catherine Vrentas

25 Mar 2022

Contributed by Lukas

Bioanalytical assays for gene therapy programs: an interview with Catherine Vrentas by Taylor & Francis Group

The epigenetic clock

25 Mar 2022

Contributed by Lukas

In this episode, supported by Zymo Research, we discuss the epigenetic clock: what is it? How are researchers using it and what are some of the key to...

ddPCR for CGT quality control: a podcast with Mark White

21 Mar 2022

Contributed by Lukas

ddPCR for CGT quality control: a podcast with Mark White by Taylor & Francis Group

Hybrid assays: an interview with Barry Jones and Adriane Spytko

11 Mar 2022

Contributed by Lukas

In this podcast Barry Jones (Director, LC–MS Biologics and Biomarkers at Q² Solutions) and Adriane Spytko (Manager, LC–MS Biologics at Q² Soluti...

Resolving spatial biology in neuroscience

28 Feb 2022

Contributed by Lukas

In this episode of Talking Techniques, supported by Resolve BioSciences, we explore the realm of spatial biology, with a particular focus on the techn...

Introducing STEM Tea

17 Feb 2022

Contributed by Lukas

In this episode of Talking Techniques, we introduce a new podcast series, produced by BioTechnques and hosted by the enigmatic Antentor Othrell Hinton...

Cell proliferation in drug screening

25 Jan 2022

Contributed by Lukas

In this episode, supported by BioRad, we explore cell proliferation monitoring and its role in drug discovery, guided by the expert advice of Rachel P...

Tech Blast: Sanger sequencing

18 Jan 2022

Contributed by Lukas

In this Tech Blast episode, is Jay Lemke, Senior Research Scientist at Promega, provides a brief overview of Sanger sequencing, its history, working p...

Treatment options for thyroid cancer: an interview with Kate Newbold

10 Jan 2022

Contributed by Lukas

Find out about current treatment options for thyroid cancer such as the recent approval of selpercatinib for patients with an alteration in the RET ge...

Synthetic biology: from cancer to the climate crisis

21 Dec 2021

Contributed by Lukas

In this episode, we explore the field of synthetic biology. Discover the history of the field and its origins in the production of biofuels, before fr...

Tech Blast | Quality assurance in drug discovery

16 Dec 2021

Contributed by Lukas

In this Tech Blast episode, Tim Bolus, Compliance Program Manager at Molecular Devices, provides a 15-minute in-depth exploration of the regulatory la...

Establishing an epigenetic lens through which to explore infectious disease and cancer

12 Nov 2021

Contributed by Lukas

We are talking all things DNA methylation in this episode, providing a brief explanation of epigenetics and the technologies involved in the study of ...

Target enrichment for NGS: Why, how and what's next?

26 Oct 2021

Contributed by Lukas

In this episode, supported by Roche, we explore a vital aspect of many next-generation sequencing studies: target enrichment. Here, regions of interes...

Producing challenging proteins in the golden age of protein engineering

13 Oct 2021

Contributed by Lukas

In this episode, we roam the world of recombinant proteins and their production, discussing the challenges of their production, and recent evolutions ...

Analysis of nitrosamine impurities: an interview with Javier Jimenez-Villarin

21 Sep 2021

Contributed by Lukas

Analysis of nitrosamine impurities: an interview with Javier Jimenez-Villarin by Taylor & Francis Group

The evolution of PCR: From q to dd and beyond

21 Sep 2021

Contributed by Lukas

PCR has evolved rapidly over the last few years, an evolution that has been dramatically accelerated by the COVID-19 pandemic. New technologies and ap...

Data Completeness: a podcast with Dan Drozd

20 Sep 2021

Contributed by Lukas

Data Completeness: a podcast with Dan Drozd by Taylor & Francis Group

Revitalising the western blot

07 Sep 2021

Contributed by Lukas

Love it or hate it, western blotting forms the bedrock of countless studies across numerous disciplines. Explore its history, development and applicat...

Immunoassay applications: a podcast with John Chappell

02 Sep 2021

Contributed by Lukas

Immunoassay applications: a podcast with John Chappell by Taylor & Francis Group

Molecular therapeutics: how far have we come and what is on the horizon?

27 Aug 2021

Contributed by Lukas

Uncover the history of molecular therapeutics, the staggering current applications and developments of these therapeutics and what their future could ...

Adeno-associated viral therapies: harnessing the power of HPLC

18 Aug 2021

Contributed by Lukas

This episode centers on the critical role that high-performance liquid chromatography (HPLC) plays in the production of adeno-associated viral (AAV) t...

Organoids: advancing drug discovery and cancer research

16 Aug 2021

Contributed by Lukas

As the transition from 2D to 3D cell cultures, or organoids, as the gold standard for modeling basic biology and disease continues, these models are b...

Automation of ADME: a podcast with Prakash Bhosale

16 Aug 2021

Contributed by Lukas

Automation of ADME: a podcast with Prakash Bhosale by Taylor & Francis Group

Taking an assay from bench to an automated platform: a podcast with Jason Evans

23 Jul 2021

Contributed by Lukas

In this podcast interview, Jason Evans (Scientist at Q² Solutions; NY, USA) discusses the importance of automation and key advantages of taking an as...

The ethics of whole-genome sequencing: from race and religion to science fiction

25 Jun 2021

Contributed by Lukas

Welcome to part 2 of this two-part episode on whole-genome sequencing (WGS) in rare disease research and treatment. In part one we discussed the impac...

Revitalising the western blot

21 Jun 2021

Contributed by Lukas

Love it or hate it, western blotting forms the bedrock of countless studies across numerous disciplines. Explore its history, development and applicat...

From space to the streets: infectious disease sampling in extreme conditions and extraordinary circumstances

18 Jun 2021

Contributed by Lukas

In this episode, we take a look at one of the key steps of infectious disease research, sample collection; exploring the challenges associated with th...

Revealing the regulome: using multiomic approaches to explore epigenetics and DNA expression

11 Jun 2021

Contributed by Lukas

Explore the realm of epigenetics and gene expression, discovering the different omic ‘lenses’ used to examine these processes and the power of sin...

Cryopreservation of advanced therapy medicinal products: an interview with Brian Hawkins

10 Jun 2021

Contributed by Lukas

Cryopreservation of advanced therapy medicinal products: an interview with Brian Hawkins by Taylor & Francis Group

The oncolytic trojan horse: Immune cells, the tumour microenvironment and the invasion of neurons

28 May 2021

Contributed by Lukas

This episode, supported by Bethyl, delves into the realm of the tumor microenvironment (TME), exploring the cells that reside there and how they inter...

Whole-genome-sequencing: navigating the "Diagnostic Odyssey" in rare disease research

19 May 2021

Contributed by Lukas

Rare diseases present a series of challenges on numerous fronts. From simply deciphering what a patient is affected by to considering how best to mana...

In the Zone: phosphorylated biomarkers

29 Apr 2021

Contributed by Lukas

In the Zone: phosphorylated biomarkers by Taylor & Francis Group

Environmental sequencing for COVID-19

19 Apr 2021

Contributed by Lukas

In this episode, we explore the often overlooked technique of environmental sequencing for infectious diseases and how it is being applied to the resp...

Implementing sensors into cell culture systems: an interview with Abbie Underhill

14 Apr 2021

Contributed by Lukas

In this podcast, Tristan Free – Digital Editor at RegMedNet – speaks to Abbie Underhill (Scientific Bioprocessing) about the role that sensors hav...

How PCR has prevailed during the COVID-19 pandemic

30 Mar 2021

Contributed by Lukas

In Part 3 of our COVID-19 diagnostics and detection miniseries, supported by Roche, we explore the contribution PCR has made towards diagnosis during ...

Reproducibility in microbiomics

25 Mar 2021

Contributed by Lukas

Returning to the contentious topic of the Reproducibility crisis – the inability of many study results to be replicated by different research g...

Spotlight: precision medicine and companion diagnostics

22 Mar 2021

Contributed by Lukas

Spotlight: precision medicine and companion diagnostics by Taylor & Francis Group

Virtual audits: limitations and future trends

11 Mar 2021

Contributed by Lukas

Virtual audits: limitations and future trends by Taylor & Francis Group

How can we achieve gender equality in STEM?

05 Mar 2021

Contributed by Lukas

This International Women’s Day takeover episode, with special guest host BioTechniques’ Senior Digital Editor Abi Sawyer, takes a look at the resu...

3DMedNet International Women's Day: an interview with Lee-Bath Nelson

02 Mar 2021

Contributed by Lukas

3DMedNet International Women's Day: an interview with Lee-Bath Nelson by Taylor & Francis Group

COG-UK: sequencing SARS-CoV-2 and detecting the novel variant B.1.1.7

18 Feb 2021

Contributed by Lukas

This episode takes a look at the role the COVID-19 Genomics UK Consortium (COG-UK) has played sequencing SARS-CoV-2 and surveying for COVID-19. To do ...

In the Zone: how do we decide a vaccine is effective?

03 Feb 2021

Contributed by Lukas

In the Zone: how do we decide a vaccine is effective? by Taylor & Francis Group

COVID-19 diagnostics: which should you choose?

15 Jan 2021

Contributed by Lukas

RT-PCR, antigen and antibody testing; each has its niche and each has a flaw. But what are the key differences between each of these tests and when wh...

The importance of bacteriophage collections

09 Nov 2020

Contributed by Lukas

In this podcast, Juandem Agendia and Sarah Alexander (NCTC, UK) discuss bacteriophages, the function of the NCTC and the importance of depositing bact...

OCTalks: Comprehensive Genomic Profiling

09 Nov 2020

Contributed by Lukas

OCTalks: Comprehensive Genomic Profiling by Taylor & Francis Group

OCTalks: the ethics of COVID-19 and cancer

09 Nov 2020

Contributed by Lukas

OCTalks: the ethics of COVID-19 and cancer by Taylor & Francis Group

OCTalks: targeting FGFR2 in advanced cholangiocarcinoma

21 Oct 2020

Contributed by Lukas

OCTalks: targeting FGFR2 in advanced cholangiocarcinoma by Taylor & Francis Group

The importance of data management: an interview with Xiaonan Tang

21 Sep 2020

Contributed by Lukas

The importance of data management: an interview with Xiaonan Tang by Taylor & Francis Group

Streamlining drug development: an interview with Brendan Griffin

03 Jul 2020

Contributed by Lukas

Brendan Griffin (University College Cork, Ireland)discusses his work in early drug development in this interview with Bioanalysis Zone. Brendan talks ...

Technique Blast | HPLC and Chromatographic Separation Technologies

18 Jun 2020

Contributed by Lukas

In this Technique Blast – a new series that will provide short informative discussions about a specific technique – Digital Editor Tristan Free sp...

3DMedTALKS | The additive response to COVID-19

08 Jun 2020

Contributed by Lukas

In the face of the COVID-19 pandemic, innovators are finding novel ways to apply 3D-printed solutions to assist the international response to coronavi...

Integrating patient-relevant outcomes into clinical practice: an interview with Donna Messner

05 Jun 2020

Contributed by Lukas

Integrating patient-relevant outcomes into clinical practice: an interview with Donna Messner by Taylor & Francis Group

NCTalks with Gavin Giovannoni: advancements in the treatment landscape for multiple sclerosis

18 May 2020

Contributed by Lukas

NCTalks with Gavin Giovannoni: advancements in the treatment landscape for multiple sclerosis by Taylor & Francis Group

Comparing real-world and randomized controlled trial data: an interview with Michael Moran

30 Apr 2020

Contributed by Lukas

Comparing real-world and randomized controlled trial data: an interview with Michael Moran by Taylor & Francis Group

Talking Techniques | UV LEDs for disinfection and potential protection from SARS-CoV-2

24 Apr 2020

Contributed by Lukas

BioTechniques Digital Editor Tristan Free, speaks to Application Scientist Theresa Thompson and Strategy Director Jay Pasquantonio (both Phoseon Techn...

Estimating the opportunity–cost-based cost–effectiveness threshold: a panel discussion

22 Apr 2020

Contributed by Lukas

Estimating the opportunity–cost-based cost–effectiveness threshold: a panel discussion by Taylor & Francis Group

Talking Techniques: Donald Ingber on COVID-19, organ-on-a-chip technology and the Wyss Institute

14 Apr 2020

Contributed by Lukas

In the first installment of this two-part episode with Donald Ingber, Founding Director of the Wyss Institute (MA, USA), we discuss his invention of o...

Talking Techniques | Microbiome studies; big data analysis, LCMS and at-home fecal sample collection

23 Mar 2020

Contributed by Lukas

In this episode BioTechniques Digital Editor, Tristan Free speaks to Annie Evans, Director of R&D and David Foster, Vice President of Data and Informa...

Talking Techniques | Paul Brennan: repairing nerve damage and addressing Alzheimer's

17 Feb 2020

Contributed by Lukas

In this episode BioTechniques Digital Editor, Tristan Free, speaks to Paul Brennan, President and CEO of NervGen, about the company's new technique, c...

Talking Techniques | Andrea Brand on neural stem cells, brain cancer and TADA!

04 Feb 2020

Contributed by Lukas

Talking at ASCB 2019 in Washington, Andrea Brand, Head of the Gurdon Institute's Wellcome labs, and BioTechniques Digital Editor Tristan Free, discus...

How is artificial intelligence changing clinical trial feasibility and recruitment?

07 Jan 2020

Contributed by Lukas

Hello, and welcome to this episode of OC talks Podcast Series brought to you by Oncology Central. I am Jade Parker, Senior Editor of Oncology Central,...

Talking Techniques| Stephen Taylor on virtual reality in the life sciences

20 Nov 2019

Contributed by Lukas

Digital Editor Tristan Free and Digital Intern Theo Kemp, speak to Stephen Taylor of The MRC Weatherall Institute of Molecular Medicine. Stephen discu...

The vitality of vital statistics: an interview with Alan Lopez

12 Nov 2019

Contributed by Lukas

The vitality of vital statistics: an interview with Alan Lopez by Taylor & Francis Group

Future Science Future Star Award - Interview with the 2019 winner

06 Nov 2019

Contributed by Lukas

Editor Jennifer Straiton speaks to the winner of the 2019 Future Science Future Star Award, Marjorie Pizarro-Guajardo. Marjorie is a postdoctoral fell...

Predicting treatment response in ovarian cancer: a peek behind the DISCOVAR trial

09 Oct 2019

Contributed by Lukas

Welcome to this episode of OC Talks Podcast Series brought to you by Oncology Central. In this episode today of OC talks we will be speaking to Nandit...

Talking Techniques | Rob Knight on precision medicine, scientific heroes and sage advice

07 Oct 2019

Contributed by Lukas

Rob Knight speaks to BioTechniques Managing Editor, Joseph Martin, about the upcoming BioTechniques Online Event: Advancing Precision Medicine 2019, h...

Challenges and applications of HRMS: a podcast with Jason Causon

07 Oct 2019

Contributed by Lukas

In this podcast, Jason Causon (Technical Product Manager at SCIEX, Canada) discusses his experience with HRMS and the current research focuses at SCIE...

The role of HRMS in DMPK analysis: a podcast with Mark Wrona

07 Oct 2019

Contributed by Lukas

In this podcast, Mark Wrona (Principal Scientist at Waters Corporation; MA, USA) discusses his experience with HRMS and the current trends in the fiel...

HRMS in DMPK: an interview with Szabolcs Szarka

07 Oct 2019

Contributed by Lukas

Szabolcs Szarka (LGC) discusses the challenges, benefits and what the future may hold for HRMS in this podcast, exclusive to the Bioanalysis Zone Spot...

Talking Techniques| Hans Keirstead on precision therapeutics for cancer and science in politics

02 Oct 2019

Contributed by Lukas

Hans Kierstead, CEO and founder of Aivita Biomedical, Speaks to Tristan Free, Digital Editor of BioTechniqes. Hans delves into his company's exciting ...

Expert discussion: challenges facing the modern bioanalyst

02 Oct 2019

Contributed by Lukas

In this podcast, senior scientists from Alturas Analytics (ID, USA), Katherine Yahvah, Chad Christianson and Michael Williams discuss some of the chal...

Joanne Hackett on DNA sequencing, 5 million genomes & precision medicine

16 Sep 2019

Contributed by Lukas

Joanne Hackett, Chief Commercial Officer at Genomics England, discusses their goals, completing major milestones in genomics research and approaching ...

OCTALKS l Breaking through limits in lung cancer survival with Patrick Connor

09 Sep 2019

Contributed by Lukas

Jade Parker, Senior Editor of Oncology Central is joined by Patrick Connor from AstraZeneca to discuss the Lung Ambition Alliance to find out how the ...

Key challenges in Peptide Bioanalysis Sample Preparation

06 Sep 2019

Contributed by Lukas

In this interview, we talk to Mary Lame, Principal Applications Scientist who supports discovery bioanalysis for both large and small molecules, provi...

3DMedTALKS l 3D printing for spinal cord injury research

29 Aug 2019

Contributed by Lukas

Georgi Makin, Editor of 3DMedNet, is joined by Jacob Koffler (University of California San Diego; CA, USA) as they discuss how 3D printing is being us...

Talking Techniques | Greg Michelotti on metabolomics, precision medicine and frailty biomarkers

02 Aug 2019

Contributed by Lukas

BioTechniques Digital and Assistant Editors Abigail Sawyer and Tristan Free talk to Greg Mitchelotti of Metabolon about metabolomics, its potential ap...

Embryonic stem cells in clinical research: hear from Takara Bio

30 Jul 2019

Contributed by Lukas

In this interview, hear from Catharina Brandsten, Head of Tissue Establishment and Kristina Runeberg, Site Head, at Takara Bio Europe, about deriving ...

Advancing mass spectrometry technologies: an interview with Neil Walsh

24 Jul 2019

Contributed by Lukas

Hear more about the recent mass spectrometry product launches from SCIEX announced at ASMS 2019, including the new Acoustic Ejection Mass Spectrometry...

Understanding automation in cell therapy manufacturing: an interview with Markus Gershater

08 Jul 2019

Contributed by Lukas

Understanding automation in cell therapy manufacturing: an interview with Markus Gershater by Taylor & Francis Group

Talking Tech News | Theo Roth on CRISPR, CAR-T and gene editing ethics

21 Jun 2019

Contributed by Lukas

BioTechniques Digital and Assistant Editors Abigail Sawyer and Tristan Free talk to Theo Roth from the University of California San Francisco Marson L...

Cell therapy: an interview with David Harris

17 Jun 2019

Contributed by Lukas

In this interview, David Harris (Charles River Laboratories; NC, USA) discusses the current global landscape for cell therapy, associated safety conce...

CAR-T cell development: an interview with Michael Schwenkert

17 Jun 2019

Contributed by Lukas

Discover more about the development of CAR-T cell therapies, their bioanalytical challenges and specialized antibody reagents that can be ustilized to...

Talking Tech News | Antibodies: will their star continue to rise?

07 Jun 2019

Contributed by Lukas

Abigail Sawyer and Tristan Free, from the BioTechniques digital team, speak to Head of Open Access Publishing at Future Science Group, Francesca Lake ...

Immunogenicity with Eric Bonner (Eurofins)

17 May 2019

Contributed by Lukas

Eric Bonner (Eurofins) discusses the techniques he uses for assessing immunogenicity, key challenges and what the future may hold for the field in thi...

3DMedTALKS l 3D printing and patient experience with surgery

14 May 2019

Contributed by Lukas

Georgi Makin, Editor of 3DMedNet, is joined by Jade Parker (Oncology Central) and Shana Cook (Milwaukee School of Engineering) as they discuss how pat...

Exosomes in flow cytometry: an interview with Joyce Slusser

01 May 2019

Contributed by Lukas

Find out more about the role of exosomes in flow cytometry studies in this interview Joyce Slusser (KCAS; KS, USA).

Flow cytometry: an interview with Clara Brando and Ted Baginski

01 May 2019

Contributed by Lukas

Find out more about current challenges and recent developments in seen in the field of flow cytometry in this interview with Clara Brando and Ted Bagi...

Gene therapy: an interview with Hugh Davis

03 Apr 2019

Contributed by Lukas

In this podcast, Hugh Davis (Frontage Laboratories; PA, USA) discusses the challenges associated with gene therapy and what the future may hold for th...

Talking Tech News | Cerebral Organoids: Past Present Future

01 Apr 2019

Contributed by Lukas

Abigail Sawyer and Tristan Free from the BioTechniques editorial team talk to Assistant Editor, Jenny Straiton about her recent Tech news piece on Ce...

CAR-T cell immunotherapy: an interview with Marco Ruella

26 Feb 2019

Contributed by Lukas

Find out more about the challenges associated with CAR-T cell immunotherapies and what the future may hold for the field in this interview with Marco ...

Talking Tech News| The Unsustainable Lab: single use plastics, digesting PET and shutting the sash.

13 Feb 2019

Contributed by Lukas

Abigail Sawyer and Tristan Free from the BioTechniques editorial team discuss the recently published tech news piece on unsustainability in the lab an...

Fake news, the reproducibility crisis & politics - science communication with Gareth Mitchell

17 Jan 2019

Contributed by Lukas

Fake news, the reproducibility crisis and politics are all reasons why the public may distrust science. We spoke to Gareth Mitchell, host on the BBC W...

Drug discovery at WCAIR: an interview with Paul Wyatt

26 Nov 2018

Contributed by Lukas

In this interview Paul Wyatt, University of Dundee (Scotland) describes the work taking place at the Wellcome Center for Anti-Infectives Research into...

«« ← Prev Page 2 of 4 Next → »»